Skip to main content
Download PDF

Correction to: Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients

Cancer Cell International volume 19, Article number: 14 (2019) Cite this article

The Original Article was published on 22 December 2018

Correction to: Cancer Cell Int (2018) 18:215 https://doi.org/10.1186/s12935-018-0716-7

Following publication of the original article [1], we have been notified that the data in Fig. 1 was wrongly presented. The correct Fig. 1 is presented below.

Fig. 1
figure 1

Circos plots depicting the relative frequencies and pairwise co-occurrences of selected common genetic alterations: in all AML patients (a), separately in patients 60 years or older (b) and in patients younger than 60 years (c). The length of the arc corresponds to the frequency of the first gene mutation, and the width of the ribbon corresponds to the proportion of co-occurrence with the second gene mutation. Both the distribution of gene mutations and the pattern of mutation co-occurrences appear to be distinct between older and younger AML patients

Full size image

Reference

  1. Cao X-x, Cai H, Mao Y-y, Wu Q. Zhang Lu, Zhou D-b, Jian L. Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients. Cancer Cell Int. 2018;18:215. https://doi.org/10.1186/s12935-018-0716-7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Author notes

  1. Xin-xin Cao and Hao Cai contributed equally to this work

Authors and Affiliations

  1. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 1 Shuai Fu Yuan Hu Tong, Dongcheng District, Beijing, 100730, People’s Republic of China

    Xin-xin Cao, Hao Cai, Yue-ying Mao, Qi Wu, Lu Zhang, Dao-bin Zhou & Jian Li

Authors
  1. Xin-xin Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hao Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yue-ying Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qi Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dao-bin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian Li.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cao, Xx., Cai, H., Mao, Yy. et al. Correction to: Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients. Cancer Cell Int 19, 14 (2019). https://doi.org/10.1186/s12935-019-0736-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12935-019-0736-y

Cancer Cell International

ISSN: 1475-2867

Contact us